Resensitizing the Imatinib-Resistant Chronic Myeloid Leukemia through Reshaping the Glucose Mtabolism By Insulin Sensitizer

被引：0
|
作者：
Lai, Qian [1 ]
Duan, Hongpeng [2 ]
Jiang, Yuelong [2 ]
Yang, Liuzhen [2 ]
Deng, Manman [3 ]
Lin, Zhijuan [4 ,5 ]
Shan, Weihang [2 ]
Zhong, Mengya [2 ]
Yao, Jingwei [2 ]
Zhang, Li [2 ]
Zha, Jie [4 ,5 ]
Xu, Bing [2 ]
机构：
[1] Xiamen Univ, Affiliated Hosp 1, Hematol, Xiamen, Peoples R China
[2] Xiamen Univ, Affiliated Hosp 1, Xiamen, Peoples R China
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[4] Xiamen Univ, Affiliated Hosp 1, Dept Hematol, Xiamen, Peoples R China
[5] Xiamen Univ, Inst Hematol, Sch Med, Xiamen, Peoples R China
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-208054
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5781 / 5781
页数：1
相关论文
共 50 条
  • [1] Management of imatinib-resistant patients with chronic myeloid leukemia
    Bhamidipati, Pavan Kumar
    Kantarjian, Hagop
    Cortes, Jorge
    Cornelison, A. Megan
    Jabbour, Elias
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2013, 4 (02) : 103 - 117
  • [2] An activating KRAS mutation in imatinib-resistant chronic myeloid leukemia
    Agarwal, A.
    Eide, C. A.
    Harlow, A.
    Corbin, A. S.
    Mauro, M. J.
    Druker, B. J.
    Corless, C. L.
    Heinrich, M. C.
    Deininger, M. W.
    LEUKEMIA, 2008, 22 (12) : 2269 - 2272
  • [3] An activating KRAS mutation in imatinib-resistant chronic myeloid leukemia
    A Agarwal
    C A Eide
    A Harlow
    A S Corbin
    M J Mauro
    B J Druker
    C L Corless
    M C Heinrich
    M W Deininger
    Leukemia, 2008, 22 : 2269 - 2272
  • [4] Effects of carboxyamidotriazole on in vitro models of imatinib-resistant chronic myeloid leukemia
    Alessandro, Riccardo
    Fontana, Simona
    Giordano, Margherita
    Corrado, Chiara
    Colomba, Paolo
    Flugy, Anna Maria
    Santoro, Alessandra
    Kohn, Elise C.
    De Leo, Giacomo
    JOURNAL OF CELLULAR PHYSIOLOGY, 2008, 215 (01) : 111 - 121
  • [5] Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib
    Chuah, Charles
    Melo, Junia V.
    ONCOTARGETS AND THERAPY, 2009, 2 : 83 - 94
  • [6] DASATINIB TREATMENT OF IMATINIB-RESISTANT AND IMATINIB-INTOLERANT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN A CHRONIC PHASE
    Vinogradova, O. Yu.
    Turkina, A. G.
    Vorontsova, A. V.
    Chelysheva, E. Yu.
    Gusarova, G. A.
    Kuznetsov, S. V.
    Goryacheva, S. R.
    Sokolova, M. A.
    Abakumov, E. M.
    Stakhina, O. V.
    Domracheva, E. V.
    Misyurin, A. V.
    Khoroshko, N. D.
    TERAPEVTICHESKII ARKHIV, 2009, 81 (07) : 41 - 46
  • [7] Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients
    Frank, O.
    Brors, B.
    Fabarius, A.
    Li, L.
    Haak, M.
    Merk, S.
    Schwindel, U.
    Zheng, C.
    LEUKEMIA, 2006, 20 (08) : 1400 - 1407
  • [8] Regulatory network analysis of microRNAs and genes in imatinib-resistant chronic myeloid leukemia
    Soltani, Ismael
    Gharbi, Hanen
    Ben Hassine, Islem
    Bouguerra, Ghada
    Douzi, Kais
    Teber, Mouheb
    Abbes, Salem
    Menif, Samia
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2017, 17 (2-3) : 263 - 277
  • [9] Regulatory network analysis of microRNAs and genes in imatinib-resistant chronic myeloid leukemia
    Ismael Soltani
    Hanen Gharbi
    Islem Ben Hassine
    Ghada Bouguerra
    Kais Douzi
    Mouheb Teber
    Salem Abbes
    Samia Menif
    Functional & Integrative Genomics, 2017, 17 : 263 - 277
  • [10] Celecoxib suppresses autophagy and enhances cytotoxicity of imatinib in imatinib-resistant chronic myeloid leukemia cells
    Lu, Ying
    Liu, Ling-Ling
    Liu, Shou-Sheng
    Fang, Zhi-Gang
    Zou, Yong
    Deng, Xu-Bin
    Long, Zi-Jie
    Liu, Quentin
    Lin, Dong-Jun
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
12345